Table 4 Risk of occurrence of cardiac arrest among patients to whom the donor management checklist was applied according to the meeting of treatment goals
Goal met (population analyzed) | Total, n = 382 | Cardiac arrests, n = 97 (25.4 %) | OR (95 % CI) | p value |
|---|---|---|---|---|
Duration of protocol 12–24 h, n (%) (all) | ||||
 Yes | 101 (26.4) | 19 (18.1) | 0.60 (0.34; 1.06) | 0.07 |
 No | 281 (73.6) | 78 (27.7) |  |  |
Temperature > 35 ° C, n (%) (all) | ||||
 Yes | 283 (74.1) | 60 (21.2) | 0.48 (0.27; 0.74) | 0.001 |
 No | 99 (25.9) | 37 (37.3) |  |  |
MAP > 65 mmHg, n (%) (all) | ||||
 Yes | 285 (74.6) | 60 (21.1) | 0.43 (0.26; 0.71) | <0.001 |
 No | 97 (25.4) | 37 (38.1) |  |  |
Diuresis from 1 to 4Â ml/kg/h, n (%) (all) | ||||
 Yes | 210 (54.9) | 49 (23.3) | 0.78 (0.49; 1.24) | 0.30 |
 No | 172 (45.1) | 48 (27.9) |  |  |
Corticosteroids, n (%) (all) | ||||
 Yes | 263 (68.8) | 56 (21.3) | 0.51 (0.32; 0.83) | 0.006 |
 No | 119 (31.2) | 41 (34.4) |  |  |
Vasopressin, n (%) (vasoconstrictor use, n = 236) | ||||
 Yes | 41(17.4) | 5 (12.2) | 0.37 (0.13; 0.99) | 0.042 |
 No | 195 (82.6) | 53 (27.1) |  |  |
Mechanical ventilation, n (%) (all) | ||||
 Yes | 256 (67.1) | 61 (23.8) | 0.78 (0.48; 1.27) | 0.32 |
 No | 126 (32.9) | 36 (28.6) |  |  |
Sodium < 150 mEq/L, n (%) (all) | ||||
 Yes | 142 (37.2) | 36 (25.4) | 0.99 (0.61; 1.60) | 0.99 |
 No | 240 (62.8) | 61 (25.5) |  |  |
Blood glucose < 180 mg/dl, n (%) (all) | ||||
 Yes | 151 (39.5) | 39 (25.8) | 1.03 (0.64; 1.66) | 0.87 |
 No | 231 (60.5) | 58 (25.1) |  |  |